United States

People: Nike Inc (NKE.N)

NKE.N on New York Stock Exchange

24 Feb 2017
Change (% chg)

$0.47 (+0.82%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Lechleiter, John 

Dr. John C. Lechleiter, Ph.D., is an Independent Director of Nike, Inc. He is Chairman of the Board, President, and Chief Executive Officer of Eli Lilly and Company (“Lilly”). He has served as President and Chief Executive Officer since April 1, 2008. He has been a member of Lilly’s Board of Directors since 2005 and was named Chairman on January 1, 2009. Dr. Lechleiter began work at Lilly as a senior organic chemist in Lilly’s process research and development division in 1979. He is a member of the American Chemical Society and Business Roundtable. He serves on the board of Pharmaceutical Research and Manufacturers of America. He also serves as Chairman of the U.S. Japan Business Council and of United Way Worldwide, and on the boards of the Life Sciences Foundation, the Central Indiana Corporate Partnership, and Ford Motor Company. Dr. Lechleiter was selected to serve on NIKE’s Board because his operational executive experience and his knowledge of science, marketing, management, and international business allow him to provide the Board with significant contributions in those strategic areas.

Basic Compensation

Total Annual Compensation, USD 85,000
Restricted Stock Awards, USD 160,005
Long-Term Incentive Plans, USD --
All Other, USD 21,093
Fiscal Year Total, USD 266,098

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --